Iravani A - Search Results

1

Novel radionuclide therapy combinations in prostate cancer.

Inderjeeth AJ, Iravani A, Subramaniam S, Conduit C, Sandhu S. Inderjeeth AJ, et al. Among authors: iravani a. Ther Adv Med Oncol. 2023 Aug 2;15:17588359231187202. doi: 10.1177/17588359231187202. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37547444 Free PMC article. Review.

2

¹⁸F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine.

Steinberg J, Thomas A, Iravani A. Steinberg J, et al. Among authors: iravani a. Lancet. 2021 Mar 20;397(10279):e9. doi: 10.1016/S0140-6736(21)00464-5. Epub 2021 Mar 8. Lancet. 2021. PMID: 33705696 Free PMC article. No abstract available.

3

RESIST-PC: U.S. Academic Foray into PSMA Theranostic Trials.

Iravani A, Hope TA. Iravani A, et al. J Nucl Med. 2021 Oct;62(10):1438-1439. doi: 10.2967/jnumed.121.262602. Epub 2021 Aug 5. J Nucl Med. 2021. PMID: 34353872 Free article. No abstract available.

4

Outcome of coronary artery bypass grafting in patients without major risk factors and patients with at least one major risk factor for coronary artery disease.

Nozari Y, Hashemlu A, Hatmi ZN, Sheikhvatan M, Iravani A, Bazdar A, Babakhan N, Ghasri NG. Nozari Y, et al. Among authors: iravani a. Indian J Med Sci. 2007 Oct;61(10):547-54. Indian J Med Sci. 2007. PMID: 17932445

5

Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study.

Iravani AT, Saeedi MM, Pakravesh J, Hamidi S, Abbasi M. Iravani AT, et al. Endocr Pract. 2008 May-Jun;14(4):458-64. doi: 10.4158/EP.14.4.458. Endocr Pract. 2008. PMID: 18558600

6

Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns.

Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, James SS, Zanzonico PB. Sgouros G, et al. Among authors: iravani a. J Nucl Med. 2021 Dec;62(Suppl 3):12S-22S. doi: 10.2967/jnumed.121.262750. J Nucl Med. 2021. PMID: 34857617 Free article. Review.

7

Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice.

Pandit-Taskar N, Iravani A, Lee D, Jacene H, Pryma D, Hope T, Saboury B, Capala J, Wahl RL. Pandit-Taskar N, et al. Among authors: iravani a. J Nucl Med. 2021 Dec;62(Suppl 3):60S-72S. doi: 10.2967/jnumed.121.262977. J Nucl Med. 2021. PMID: 34857623 Free article. Review.

8

Tc-99m DMSA SPECT imaging in patients with acute symptoms or history of UTI. Comparison with ultrasonography.

Mastin ST, Drane WE, Iravani A. Mastin ST, et al. Among authors: iravani a. Clin Nucl Med. 1995 May;20(5):407-12. doi: 10.1097/00003072-199505000-00006. Clin Nucl Med. 1995. PMID: 7628142

9

Pancreatic neuroendocrine neoplasms: a 2022 update for radiologists.

Galgano SJ, Morani AC, Gopireddy DR, Sharbidre K, Bates DDB, Goenka AH, Arif-Tiwari H, Itani M, Iravani A, Javadi S, Faria S, Lall C, Bergsland E, Verma S, Francis IR, Halperin DM, Chatterjee D, Bhosale P, Yano M. Galgano SJ, et al. Among authors: iravani a. Abdom Radiol (NY). 2022 Dec;47(12):3962-3970. doi: 10.1007/s00261-022-03466-9. Epub 2022 Mar 4. Abdom Radiol (NY). 2022. PMID: 35244755 Review.

10

Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns.

Wahl RL, Sgouros G, Iravani A, Jacene H, Pryma D, Saboury B, Capala J, Graves SA. Wahl RL, et al. Among authors: iravani a. J Nucl Med. 2021 Dec;62(Suppl 3):23S-35S. doi: 10.2967/jnumed.121.262751. J Nucl Med. 2021. PMID: 34857619 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters